Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 20 - Number 7

Review Article

Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia

, 20(7): 473 - 489

Vaibhav Agrawal*, Olumide B. Gbolahan, Maximilian Stahl, Amer M. Zeidan, Mohammad Abu Zaid, Sherif S. Farag and Heiko Konig*

DOI: 10.2174/1568009620666200502011059

Review Article

Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment

, 20(7): 501 - 512

Rebecca H. Horton, Tom Wileman and Stuart A. Rushworth*

DOI: 10.2174/1568009620666200428111051

Review Article

FLT3 Inhibition in Acute Myeloid Leukaemia – Current Knowledge and Future Prospects

, 20(7): 513 - 531

Francesca L. Hogan, Victoria Williams and Steven Knapper*

DOI: 10.2174/1570163817666200518075820

Review Article

The Evolving AML Genomic Landscape: Therapeutic Implications

, 20(7): 532 - 544

Sachi Horibata*, George Alyateem, Christin B. DeStefano and Michael M. Gottesman*

DOI: 10.2174/1568009620666200424150321

Review Article

Immune Checkpoint Inhibitors in AML-A New Frontier

, 20(7): 545 - 557

Rohit Thummalapalli, Hanna A. Knaus, Ivana Gojo and Joshua F. Zeidner*

DOI: 10.2174/1568009620666200421081455


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog